Teva-Cotridin (2020-06-01)

Teva-Cotridin (2020-06-01) - Recalls and safety alerts
Starting date:
June 1, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-73273

Last updated:

2020-06-09
  • Product: Teva-Cotridin Syrup

Affected lots contain Codeine Phosphate levels outside of the labelled claim.

Wholesalers, Retailers

 
DIN 02169126

Syrup

  • Codeine phosphate 10 mg/5 mL
  • Pseudoephedrine hydrochloride 30 mg/5 mL
  • Triprolidine hydrochloride 2 mg/5 mL

680026, 680046

Recalling Firm
Teva Canada Ltd. 30 Novopharm Court Toronto M1B 2K9 Ontario CANADA

 

Marketing Authorization Holder
Teva Canada Ltd. 30 Novopharm Court Toronto M1B 2K9 Ontario CANADA

To read more Press Release articles, click here.